Position in NVO
as of Jun 30, 2026
· filed Jul 20, 2026
Position Value
$4,893,187
+$1,255,305 QoQ
Shares Held
102,069
+3.1% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
0.97%
of 13F equity value
Holder Rank
#225
of 1,348 holders
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in NVO Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026SMITHBRIDGE ASSET MANAGEMENT INC/DE holds $39,618,201 across 7 Drug Manufacturers - General names. NVO ranks #5 (12.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
43,597 | $11,072,330 | |
| 2 | NVS |
Novartis AG
|
49,133 | $7,700,123 | |
| 3 | ABBV |
AbbVie Inc.
|
29,215 | $7,351,662 | |
| 4 | LLY |
ELI LILLY & Co
|
5,883 | $7,056,247 | |
| 5 | NVO |
Novo Nordisk A S
This page
|
102,069 | $4,893,187 | |
| 6 | MRK |
Merck & Co., Inc.
|
10,048 | $1,291,168 | |
| 7 | AMGN |
Amgen Inc
|
700 | $253,484 |
All Filings in NVO
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $4,893,187 | 102,069 | Shares | Sole | 2026-07-20 | |
| 2026-03-31 | $3,637,882 | 98,990 | Shares | Sole | 2026-04-24 | |
| 2025-12-31 | $10,134,685 | 199,188 | Shares | Sole | 2026-02-11 | |
| 2025-09-30 | $5,242,639 | 94,479 | Shares | Sole | 2025-10-29 | |
| 2025-06-30 | $6,324,578 | 91,634 | Shares | Sole | 2025-07-29 | |
| 2025-03-31 | $6,147,592 | 88,531 | Shares | Sole | 2025-04-16 | |
| 2024-09-30 | $10,611,518 | 89,120 | Shares | Sole | 2024-10-24 | |
| 2024-06-30 | $13,178,755 | 92,327 | Shares | Sole | 2024-07-19 | |
| 2024-03-31 | $11,876,101 | 92,493 | Shares | Sole | 2024-05-03 | |
| 2023-12-31 | $9,891,992 | 95,621 | Shares | Sole | 2024-01-18 | |
| 2023-09-30 | $8,846,461 | 97,278 | Shares | Sole | 2023-10-25 | |
| 2023-06-30 | $8,106,550 | 50,093 | Shares | Sole | 2023-07-20 | |
| 2023-03-31 | $8,193,004 | 51,483 | Shares | Sole | 2023-04-20 | |
| 2022-12-31 | $7,267,758 | 53,700 | Shares | Sole | 2023-03-01 | |
| 2022-09-30 | $5,387,591 | 54,076 | Shares | Sole | 2022-10-25 | |
| 2022-06-30 | $5,971,422 | 53,589 | Shares | Sole | 2022-08-03 | |
| 2022-03-31 | $5,987,816 | 53,920 | Shares | Sole | 2022-04-25 | |
| 2021-12-31 | $6,073,200 | 54,225 | Shares | Sole | 2022-01-24 | |
| 2021-09-30 | $5,438,870 | 56,649 | Shares | Sole | 2021-10-04 | |
| 2021-06-30 | $4,915,288 | 58,676 | Shares | Sole | 2021-07-23 | |
| 2021-03-31 | $3,920,068 | 58,144 | Shares | Sole | 2021-04-06 | |
| 2020-12-31 | $3,986,618 | 57,074 | Shares | Sole | 2021-01-21 | |
| 2020-09-30 | $4,004,652 | 57,679 | Shares | Sole | 2020-10-29 | |
| 2020-06-30 | $3,787,952 | 57,849 | Shares | Sole | 2020-07-01 | |
| 2020-03-31 | $3,789,529 | 62,949 | Shares | Sole | 2020-04-13 | |
| No filing history on record for this holder in this stock. | ||||||